日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data

探讨淋巴结阳性、高危、激素受体阳性、HER2阴性早期乳腺癌患者的治疗差距和预后风险:真实世界数据分析

Tolaney, S M; Sammons, S; Sandoval-Leon, A; Cortes, J; Liepa, A M; Grimes, B R; He, D; Cui, Z L; Roose, J; Gathirua-Mwangi, W; Moreira, K; O'Shaughnessy, J; Neven, P; Johnston, S R D; Rugo, H S

Impact of the Eras Protocols on Costs and Benefits in Two Italian Second-Level Healthcare Centers According to the National Waiting List Management Plan (PNGLA)

根据国家候诊名单管理计划 (PNGLA),ERAS 协议对意大利两家二级医疗中心成本和收益的影响

Frattini, Francesco; Fabbi, Manrica; Bardelli, Laura; Galli, Federica; Iovino, Domenico; Liepa, Linda; Milani, Marika Sharmayne; Pappalardo, Vincenzo; Pavesi, Franco; Surace, Michele; Donnini, Luca; Baù, Diego; Poggialini, Giovanni; Covacich, Paolo; Isella, Lorenzo; Rausei, Stefano

Treatment Experience of Early-Stage Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in a Real-World Setting: European Patients' Perspectives

真实世界中早期激素受体阳性、人表皮生长因子受体2阴性乳腺癌的治疗经验:欧洲患者的视角

Banys-Paluchowski, Maggie; Lüftner, Diana; Korfel, Agnieszka; Chouaki, Nadia; Sanderson, Isaac; Barlow, Sophie G; Rider, Alex; Liepa, Astra M; Jackisch, Christian

Abemaciclib Persistence in Patients with HR+, HER2-, Node-Positive Early Breast Cancer: a Real-World Analysis

阿贝西利在HR+、HER2-、淋巴结阳性早期乳腺癌患者中的持续疗效:一项真实世界分析

Hudson, Kathryn; Gathirua-Mwangi, Wambui; Williams, Lindsay A; Cui, Zhanglin Lin; Richey, Madeline; Grimes, Brenda; Wang, Jingru; Liepa, Astra M; Brechtelsbauer, Erich; Volodarsky, Raisa; Moreira, Katheryn; Soliman, Hatem

Selective chemical tracking of DNA methylomes in live cells

活细胞中DNA甲基化组的选择性化学追踪

Stankevičius, Vaidotas; Gasiulė, Liepa; Vilkaitis, Giedrius; Klimašauskas, Saulius

Open Renal Transplantation in Obese Patients: A Correlation Study between BMI and Early and Late Complications with Implementation of a Prognostic Risk Score

肥胖患者开放式肾移植:BMI与早期和晚期并发症的相关性研究及预后风险评分的应用

Marzorati, Sara; Iovino, Domenico; Inversini, Davide; Iori, Valentina; Parise, Cristiano; Masci, Federica; Liepa, Linda; Oltolina, Mauro; Zani, Elia; Franchi, Caterina; Morabito, Marika; Gritti, Mattia; Di Bella, Caterina; Bisogno, Silvia; Mangano, Alberto; Tozzi, Matteo; Carcano, Giulio; Ietto, Giuseppe

Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States

美国晚期胃食管癌真实世界分子生物标志物检测模式及结果

Mehta, Rutika; Liepa, Astra M; Zheng, Shen; Chatterjee, Anindya

Selective chemical tracking of Dnmt1 catalytic activity in live cells

活细胞中 Dnmt1 催化活性的选择性化学追踪

Vaidotas Stankevičius, Povilas Gibas, Bernadeta Masiulionytė, Liepa Gasiulė, Viktoras Masevičius, Saulius Klimašauskas, Giedrius Vilkaitis

Vegetation Affecting Water Quality in Small Streams: Case Study in Hemiboreal Forests, Latvia

植被对小溪水质的影响:以拉脱维亚半寒带森林为例

Saklaurs, Mārcis; Dubra, Stefānija; Liepa, Līga; Jansone, Diāna; Jansons, Āris

Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain

Cl415 是一种耐碳青霉烯类鲍曼不动杆菌分离株,含有四个 AbaR4 和一个 AbGRI2 的新变体,代表了一种新型的全球克隆 2 菌株。

Liepa, Rebekah; Mann, Riti; Osman, Marwan; Hamze, Monzer; Gunawan, Cindy; Hamidian, Mohammad